Cargando…

Implications of maraviroc and/or rapamycin in a mouse model of fragility

Background: As age increases, the risk of developing fragility also increases. Improving the knowledge of frailty could contribute to maintaining the functional ability of elderly people. Interleukin (IL)-10 homozygous knockout mice (IL-10(tm/tm) [IL10KO]) constitute an excellent tool for the study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez-Martínez, Laura, Romero, Lourdes, Muñoz-Galván, Sandra, Verdugo-Sivianes, Eva M., Rubio-Mediavilla, Susana, Oteo, José A., Carnero, Amancio, Blanco, José-Ramón
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244075/ https://www.ncbi.nlm.nih.gov/pubmed/32353830 http://dx.doi.org/10.18632/aging.103167

Ejemplares similares

Chronotherapy: Circadian Rhythms and Their Influence in Cancer Therapy
por: Amiama-Roig, Ana, et al.
Publicado: (2022)

Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model
por: Ochoa-Callejero, Laura, et al.
Publicado: (2013)

Role of the Holoenzyme PP1-SPN in the Dephosphorylation of the RB Family of Tumor Suppressors During Cell Cycle
por: Verdugo-Sivianes, Eva M., et al.
Publicado: (2021)

Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells
por: Verdugo-Sivianes, Eva M, et al.
Publicado: (2021)

c‐MYB‐ and PGC1a‐dependent metabolic switch induced by MYBBP1A loss in renal cancer
por: Felipe‐Abrio, Blanca, et al.
Publicado: (2019)

Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer
por: Felipe-Abrio, Blanca, et al.
Publicado: (2019)

A Six-Gene Prognostic and Predictive Radiotherapy-Based Signature for Early and Locally Advanced Stages in Non-Small-Cell Lung Cancer
por: Peinado-Serrano, Javier, et al.
Publicado: (2022)

Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy
por: García-Heredia, José M., et al.
Publicado: (2016)

Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

A new treatment for sarcoma extracted from combination of miRNA deregulation and gene association rules
por: García-Heredia, José Manuel, et al.
Publicado: (2023)

Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2021)

Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer
por: Verdugo-Sivianes, Eva M., et al.
Publicado: (2017)

Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?
por: Amiama-Roig, Ana, et al.
Publicado: (2023)

High casein kinase 1 epsilon levels are correlated with better prognosis in subsets of patients with breast cancer
por: Lopez-Guerra, Jose Luis, et al.
Publicado: (2015)

Use of maraviroc in patients with undetectable viral load: efficacy, tolerance and predictors of viral response in MARAVIROC-cohort study
por: Jesús Pérez Elías, María, et al.
Publicado: (2014)

NAD pool as an antitumor target against cancer stem cells in head and neck cancer
por: Navas, Lola E., et al.
Publicado: (2023)

New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools
por: Muñoz-Galván, Sandra, et al.
Publicado: (2019)

Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia
por: Narlik-Grassow, Maja, et al.
Publicado: (2013)

Senotherapeutics in Cancer and HIV
por: Sánchez-Díaz, Laura, et al.
Publicado: (2022)

Maraviroc in the treatment of HIV infection
por: Ray, Neelanjana
Publicado: (2009)

Breast tumor cells promotes the horizontal propagation of EMT, stemness, and metastasis by transferring the MAP17 protein between subsets of neoplastic cells
por: García-Heredia, José Manuel, et al.
Publicado: (2020)

Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment
por: Perez, Marco, et al.
Publicado: (2020)

Correction: Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia
por: Narlik-Grassow, Maja, et al.
Publicado: (2013)

Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA
por: Perez, Marco, et al.
Publicado: (2015)

The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients
por: Ortega Gonzalez, Enrique, et al.
Publicado: (2014)

Improvement of endothelial function after switching previously treated HIV-infected patients to an NRTI-sparing bitherapy with maraviroc
por: Bernal, Enrique, et al.
Publicado: (2014)

Maraviroc: the evidence for its potential in the management of HIV
por: Profit, Louise
Publicado: (2007)

PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
por: Gonzalez-Serna, Alejandro, et al.
Publicado: (2016)

Optimizing management of treatment-naïve and treatment-experienced HIV+ patients: the role of maraviroc
por: Poveda, Eva, et al.
Publicado: (2010)

Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound
por: López-Huertas, María Rosa, et al.
Publicado: (2020)

Effect of Maraviroc Intensification on HIV-1-Specific T Cell Immunity in Recently HIV-1-Infected Individuals
por: Kawana-Tachikawa, Ai, et al.
Publicado: (2014)

Decoding Warburg's hypothesis: tumor-related mutations in the mitochondrial respiratory chain
por: Garcia-Heredia, Jose M., et al.
Publicado: (2015)

Dr. Jekyll and Mr. Hyde: MAP17’s up-regulation, a crosspoint in cancer and inflammatory diseases
por: García-Heredia, José M., et al.
Publicado: (2018)

The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment
por: García-Heredia, José M., et al.
Publicado: (2017)

NUMB and NUMBL differences in gene regulation
por: García-Heredia, José Manuel, et al.
Publicado: (2018)

Role of Mitochondria in Cancer Stem Cell Resistance
por: García-Heredia, José Manuel, et al.
Publicado: (2020)

Immunologic impact of maraviroc in clinical practice of a university hospital
por: Paniagua, S Plata, et al.
Publicado: (2010)

Incidence of ischemic cardiovascular events in the maraviroc clinical development program
por: Portsmouth, S, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_q09vlf9ijne7mtp7c39huugd6o